Localsyr.com on MSN2d
CNY man is first patient in US to receive new prostate cancer treatment in pre-chemotherapy settingOn March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate cancer pre-chemotherapy. Just six days ...
The FDA has approved Tevimbra with chemotherapy for the first-line treatment of unresectable or metastatic ESCC whose tumors express PD-L1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback